Songqiao Huang

Songqiao Huang

Novartis Institutes for BioMedical Research - Bhubaneswar / United States
Others
AD Scientific Index ID: 5517627
-
person_outline Songqiao Huang's MOST POPULAR ARTICLES
1-) Efficacy and safety of the novel glycine transporter inhibitor BI 425809 once daily in patients with schizophrenia: a double-blind, randomised, placebo-controlled phase 2 studyWW Fleischhacker, J Podhorna, M Gröschl, S Hake, Y Zhao, S Huang, ...The Lancet Psychiatry 8 (3), 191-201, 2021822021
2-) Hausdorff matching based SVD-covariance descriptor for object trackingW Guo, C Xu, S Ma, S HuangProceedings of the Second International Conference on Internet Multimedia …, 201022010
3-) Efficacy and Safety of BI 425809 Once Daily in Patients With Schizophrenia: Top-Line Phase II ResultsWW Fleischhacker, J Podhorna, M Groschl, S Hake, Y Zhao, S Huang, ...NEUROPSYCHOPHARMACOLOGY 45 (SUPPL 1), 242-242, 20202020
4-) BI 425809 Once Daily in Patients With Schizophrenia: Feasibility of Novel Endpoints to Assess MotivationB Horan, S Hake, S Huang, Y Zhao, R Keefe, A Atkins, J PodhornaNEUROPSYCHOPHARMACOLOGY 45 (SUPPL 1), 131-132, 20202020
5-) Evaluation of the efficacy and safety of orally administered BI425809 during a 12‐week treatment period compared with placebo in patients with cognitive impairment due to …G Wunderlich, Z Blahova, M Garcia Jr, S Huang, S Pollentier, F JessenAlzheimer\'s & Dementia 16, e044797, 20202020